Takeaways RJVA-002 uses gene therapy to deliver GLP-1 and GIP directly from pancreatic beta cells in a nutrient-responsive way. Preclinical studies in obese mice show up to 30% body weight loss and improved…
Takeaways Once-monthly MariTide led to up to 17.5% weight loss in 52 weeks, with minimal regain after stopping treatment. The drug combines GLP-1 and glucagon receptor activity, offering fat burn and appetite suppression…
Takeaways Emerging GPCR-targeted therapies could offer oral, appetite-modifying weight-loss options with fewer GI side effects. GSBR-1290 shows real human efficacy (~5–7% weight loss) and convenience, while BRP highlights non-incretin, central-acting alternatives in preclinical…
Takeaways Daxxify offers significantly longer-lasting results (6–9 months) compared to traditional neuromodulators, making it especially appealing for patients with hormonal fluctuations. No peer-reviewed research yet exists linking Daxxify’s use to stabilizing estrogen-influenced dermal changes,…
Takeaways Designer Estrogens 2.0 offer targeted bone and cognitive benefits while minimizing breast and uterine cancer risks. The 2025 UCSF Phase II trial shows improved bone density and memory with no evidence of…
Takeaways Controlled mitochondrial uncouplers like HU6 are in early human trials and show promise for reducing liver fat and body adiposity while preserving lean mass. Organ-targeted and prodrug delivery systems enhance safety by…
Takeaways Kisspeptin analogs like MVT‑602 restore reproductive signaling upstream of traditional therapies. These agents offer faster cycle restoration while minimizing risks of hyperstimulation or estrogen overload. Precision dosing and integrative wellness can improve…
Takeaways Dual‑pathway therapies deliver stronger, longer-lasting fat loss while preserving lean mass. AI‑guided dosing promises smarter personalization, improving adherence and real‑world outcomes. The oral and injectable co‑agonist amycretin marks a breakthrough in obesity…
Takeaways Nasal testosterone gel mimics natural hormone rhythms while preserving sperm production. It avoids partner exposure and supports high patient satisfaction through convenience. FDA-approved Natesto offers fertile men a reliable TRT option with…
Takeaways Estrogen decline during menopause accelerates muscle loss, making strength training essential. Duavee offers benefits for bone health and hot flash relief, but muscle-preservation data remains inconclusive. Combining hormone therapy with resistance training…